Almontys, Quarter

Almonty's $50 Million Quarter Rests on a Number Its Mine Never Earned

Published on 11/18/2026 at 18:31 | Editorial boerse-global.de
Almonty's C$50.24M Q3 profit was mostly a C$47.90M non-cash revaluation gain; analysts cut Sangdong-driven EBITDA forecasts while keeping Buy ratings.
Almontys, Quarter, Rests, Number, Its, Mine, Never, Earned, C$5024M, C$4790M Illustration mit AI erstellt.

Almonty Industries booked a C$50.24 million net profit in the third quarter of 2026, but C$47.90 million of that figure came from a non-cash revaluation gain rather than from the tungsten the company digs out of the ground. Strip that accounting entry out and the headline shrinks to something far closer to the operating reality of a mine still finding its feet.

The distinction matters because Sangdong, Almonty's flagship project in South Korea, only produced its first tungsten concentrate in September. A first container shipment left after the quarter closed. Those are genuine operational milestones, yet neither of them generates the kind of earnings that a C$50 million bottom line implies.

What the quarter actually delivered

Revenue for the three months reached C$41.89 million, with adjusted EBITDA of C$14.59 million. The balance sheet carried C$1.15 billion in liquid funds as of September 30. More than 90% of Phase I output is already tied up under contract, which gives the ramp-up a visible buyer base — though a signed offtake and a running plant are two different things.

That gap between contract and cash flow is where the analyst community has been sharpening its pencils. B. Riley Securities cut its price target on Monday to US$18 from US$20 while keeping a Buy rating, and slashed its fourth-quarter 2026 adjusted EBITDA estimate to US$3.6 million from US$31.3 million, citing the delayed volume contribution from Sangdong. Stifel had already trimmed its own target to US$18 from US$21 on Friday, also maintaining a Buy.

Should investors sell immediately? Or is it worth buying Almonty?

Those revisions are forecasts, not reported results. Still, the scale of the B. Riley cut — a near-90% reduction in one quarter's expected earnings — shows how tightly the investment case is now bound to the timing of Sangdong's production ramp.

A legal dispute running alongside the build-out

Separately, Deutsche Rohstoff, an Almonty shareholder, has pegged its claims against the company at roughly US$67 million, tied to conversion rights and outstanding loans. The figure describes what Deutsche Rohstoff says it is owed; it is not an established payment obligation. Deutsche Rohstoff disclosed in its quarterly report yesterday that Almonty has filed a counterclaim and that the two proceedings have been consolidated.

Deutsche Rohstoff dismissed the allegations directed at it as unfounded and largely time-barred. It had said on Wednesday that Almonty's suit mainly concerns claims connected with the 2014 sale of Wolfram Camp. Both sides, in other words, are advancing their own version of events, and neither account amounts to an independent verdict on how the dispute will end. Investors can price the litigation as a risk factor; they cannot book it as a settled expense.

Korea listing adds a capital-markets layer

Almonty also confirmed yesterday that it intends to pursue a secondary listing on the Korea Exchange, keeping its Nasdaq presence intact. The plan hinges on approval from the exchange and regulators, on market conditions, and on compliance with securities-law requirements.

A second listing changes where the shares trade and who can buy them. It does nothing to resolve the litigation or to accelerate the Sangdong ramp — and conflating those threads is precisely the trap. Three separate stories are unfolding at Almonty at once: a mine moving from first concentrate toward steady output, a profit line inflated by a valuation adjustment, and a legal fight with a major shareholder whose outcome remains open. The stock deserves to be judged on each of them individually, not on the volume of announcements coming out of the company.

Ad

Almonty Stock: New Analysis - 18 November

Fresh Almonty information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Almonty analysis...

Disclaimer...
en | CA0203987072 | ALMONTYS | boerse | 70532142 |